BEAM
Price
$27.53
Change
+$0.25 (+0.92%)
Updated
Jan 31, 11:40 AM (EDT)
Capitalization
2.26B
32 days until earnings call
PRTA
Price
$14.92
Change
+$0.22 (+1.50%)
Updated
Jan 31, 11:42 AM (EDT)
Capitalization
850.72M
13 days until earnings call
Ad is loading...

BEAM vs PRTA

Header iconBEAM vs PRTA Comparison
Open Charts BEAM vs PRTABanner chart's image
Beam Therapeutics
Price$27.53
Change+$0.25 (+0.92%)
Volume$200
Capitalization2.26B
Prothena
Price$14.92
Change+$0.22 (+1.50%)
Volume$100
Capitalization850.72M
BEAM vs PRTA Comparison Chart
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. PRTA commentary
Jan 31, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Buy and PRTA is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 31, 2025
Stock price -- (BEAM: $27.28 vs. PRTA: $14.70)
Brand notoriety: BEAM and PRTA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 92% vs. PRTA: 56%
Market capitalization -- BEAM: $2.26B vs. PRTA: $850.72M
BEAM [@Biotechnology] is valued at $2.26B. PRTA’s [@Biotechnology] market capitalization is $850.72M. The market cap for tickers in the [@Biotechnology] industry ranges from $379.55B to $0. The average market capitalization across the [@Biotechnology] industry is $2.47B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 0 FA rating(s) are green whilePRTA’s FA Score has 0 green FA rating(s).

  • BEAM’s FA Score: 0 green, 5 red.
  • PRTA’s FA Score: 0 green, 5 red.
According to our system of comparison, BEAM is a better buy in the long-term than PRTA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 3 TA indicator(s) are bullish while PRTA’s TA Score has 5 bullish TA indicator(s).

  • BEAM’s TA Score: 3 bullish, 5 bearish.
  • PRTA’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, PRTA is a better buy in the short-term than BEAM.

Price Growth

BEAM (@Biotechnology) experienced а +3.77% price change this week, while PRTA (@Biotechnology) price change was -5.04% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.09%. For the same industry, the average monthly price growth was +1.54%, and the average quarterly price growth was +5.25%.

Reported Earning Dates

BEAM is expected to report earnings on May 13, 2025.

PRTA is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (-1.09% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($2.26B) has a higher market cap than PRTA($851M). BEAM YTD gains are higher at: 10.000 vs. PRTA (6.137). BEAM (-160.83M) and PRTA (-167.23M) have comparable annual earnings (EBITDA) . BEAM has more cash in the bank: 926M vs. PRTA (519M). PRTA has less debt than BEAM: PRTA (11.5M) vs BEAM (162M). BEAM has higher revenues than PRTA: BEAM (350M) vs PRTA (133M).
BEAMPRTABEAM / PRTA
Capitalization2.26B851M265%
EBITDA-160.83M-167.23M96%
Gain YTD10.0006.137163%
P/E RatioN/AN/A-
Revenue350M133M263%
Total Cash926M519M178%
Total Debt162M11.5M1,409%
FUNDAMENTALS RATINGS
PRTA: Fundamental Ratings
PRTA
OUTLOOK RATING
1..100
5
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
95
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMPRTA
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
89%
Momentum
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
77%
MACD
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
84%
Bullish Trend 3 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
84%
Bullish Trend 3 days ago
83%
Advances
ODDS (%)
Bullish Trend 25 days ago
81%
Bullish Trend 5 days ago
76%
Declines
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 3 days ago
87%
BollingerBands
ODDS (%)
N/A
Bearish Trend 3 days ago
88%
Aroon
ODDS (%)
Bearish Trend 3 days ago
88%
N/A
View a ticker or compare two or three
Ad is loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FVDKX37.15N/A
N/A
Fidelity Value Discovery K
IAXSX10.92N/A
N/A
VY® T. Rowe Price Divers Mid Cap Gr S
GIUIX38.40N/A
N/A
NAA Mid Growth Institutional
LICVX15.24N/A
N/A
Lord Abbett International Equity R6
GSIHX20.07N/A
N/A
Goldman Sachs GQG Ptnrs Intl Opps A

PRTA and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRTA has been loosely correlated with PEPG. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if PRTA jumps, then PEPG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRTA
1D Price
Change %
PRTA100%
-7.02%
PEPG - PRTA
53%
Loosely correlated
-21.74%
DNLI - PRTA
51%
Loosely correlated
+0.73%
BEAM - PRTA
46%
Loosely correlated
+5.29%
NTLA - PRTA
42%
Loosely correlated
+3.85%
NAUT - PRTA
41%
Loosely correlated
+0.57%
More